Verano provides a superior cannabis shopping experience through Zen Leaf and MÜV dispensary banners while producing a comprehensive suite of high-quality cannabis products under its diverse brand portfolio including Verano, Essence, Savvy, BITS, Encore, and Avexia. The company remains the cheapest major MSO by EV/EBITDA with analysts expecting EBITDA growth in 2026.
Cyborg Score Rationale
Revenue declined 6.38% to $878.59 million in 2024, with losses of $341.86 million, 191% more than in 2023. Analysts expect EBITDA growth in 2026 and the company trades at a discount valuation, though recent financials have disappointed.
Top Insights
Revenue declined 6.38% YoY in 2024 to $878.59M amid significant net losses of $341.86M
Market capitalization as of February 2026 stands at $0.34 billion USD
Company employs approximately 3,800 employees as of February 2026
Trading at attractive EV/EBITDA multiple relative to peers with EBITDA growth expected in 2026
Named Competitors
Trulieve — Major U.S. multi-state cannabis operator
Curaleaf — Leading multi-state cannabis company
TerrAscend — U.S. multi-state cannabis operator
Recent Developments
(January 2026) First Amendment to credit facility increased commitment to $100 million
(December 2025) Opened new Zen Leaf location announced December 30, 2025
(September 2025) Entered into $75M revolving credit facility, drawing $50M at closing
Open the full interactive Verano Holdings Corp. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.